Clover Health Investments, Corp.
CLOV
$3.47
-$0.17-4.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.27% | 33.71% | 8.86% | 7.23% | 9.51% |
| Total Other Revenue | 22.55% | 14.62% | 36.91% | 75.22% | 10.51% |
| Total Revenue | 34.07% | 33.45% | 9.28% | 8.29% | 9.53% |
| Cost of Revenue | 52.20% | 33.29% | -2.69% | 5.93% | 1.67% |
| Gross Profit | -7.68% | 33.95% | 60.30% | 16.26% | 33.20% |
| SG&A Expenses | 9.88% | 5.69% | 6.62% | -11.22% | -4.06% |
| Depreciation & Amortization | 19.39% | 46.54% | -48.96% | -39.14% | -66.97% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.04% | 25.55% | 0.03% | 0.70% | -0.23% |
| Operating Income | -237.85% | 94.42% | 57.07% | 71.14% | 131.74% |
| Income Before Tax | -247.53% | 94.50% | 68.38% | 73.87% | 124.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -247.53% | 94.50% | 68.38% | 73.87% | 124.82% |
| Earnings from Discontinued Operations | -- | -- | 75.82% | 95.29% | 217.33% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -242.79% | 93.35% | 68.65% | 77.92% | 125.71% |
| EBIT | -237.85% | 94.42% | 57.07% | 71.14% | 131.74% |
| EBITDA | -227.22% | 96.41% | 57.18% | 71.70% | 134.54% |
| EPS Basic | -236.84% | 93.40% | 69.31% | 78.33% | 125.29% |
| Normalized Basic EPS | -232.65% | 94.54% | 58.00% | 71.67% | 131.11% |
| EPS Diluted | -298.10% | 93.40% | 68.83% | 75.90% | 117.47% |
| Normalized Diluted EPS | -235.42% | 94.54% | 58.00% | 71.67% | 130.48% |
| Average Basic Shares Outstanding | 4.42% | 2.20% | 2.13% | 1.96% | 1.74% |
| Average Diluted Shares Outstanding | 2.80% | 2.20% | 2.13% | 1.96% | 3.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |